CEO and Chair of Board, 10% Owner of Pain Therapeutics (PTIE, Financial) Remi Barbier sells 5,443 shares of PTIE on 03/03/2010 at an average price of $6.13 a share.
Pain Therapeutics has a market cap of $266.1 million; its shares were traded at around $6.3 with and P/S ratio of 12.9.
PTIE is in the portfolios of Daniel Loeb of Third Point, LLC, Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.
Pain Therapeutics has a market cap of $266.1 million; its shares were traded at around $6.3 with and P/S ratio of 12.9.
PTIE is in the portfolios of Daniel Loeb of Third Point, LLC, Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell:: CEO and Chair of the Board, 10% Owner Remi Barbier sold 44,557 shares of PTIE stock on 03/02/2010 at the average price of 6.07, the price of the stock has increased by 3.79% since.
- Sell:: CEO, President, Chairman of Bd, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 02/02/2010 at the average price of 5.32, the price of the stock has increased by 18.42% since.
- Sell:: CEO, Chairman of Board, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 01/06/2010 at the average price of 5.39, the price of the stock has increased by 16.88% since.
- Sell:: CEO,, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 11/05/2009 at the average price of 4.83, the price of the stock has increased by 30.43% since.
- Sell:: CEO, 10% Owner Remi Barbier sold 20,000 shares of PTIE stock on 10/02/2009 at the average price of 5.1, the price of the stock has increased by 23.53% since.
Directors and Officers Recent Trades:
- Sell:: COO Nadav Friedmann sold 15,000 shares of PTIE stock on 11/16/2009 at the average price of 5, the price of the stock has increased by 26% since.
- Sell:: 10% Owner Capital Management Eastbourne sold 3,076,915 shares of PTIE stock on 09/29/2009 at the average price of 4.98, the price of the stock has increased by 26.51% since.
